4.7 Review

Evidence for immune system alterations in peripheral biological fluids in Parkinson?s disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Neurosciences

Pathological α-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brain

Enquan Xu et al.

Summary: This study explores the interaction between α-synuclein and LRRK2 in monocytes and the subsequent neuroinflammatory response. The study finds that pathological α-synuclein activates LRRK2 expression and kinase activity in monocytes, leading to their recruitment to the brain. The results suggest that inhibition of LRRK2 kinase activity may attenuate damaging pro-inflammatory monocyte responses in the brain.

MOLECULAR NEURODEGENERATION (2022)

Letter Clinical Neurology

Serum Substance P Is Increased in Parkinson's Disease and Correlates with Motor Impairment

Tommaso Schirinzi et al.

MOVEMENT DISORDERS (2022)

Review Clinical Neurology

Ten Unsolved Questions About Neuroinflammation in Parkinson's Disease

Etienne C. Hirsch et al.

Summary: Parkinson's disease is a progressive and debilitating disorder with neuroinflammation playing a role in its pathophysiology. Research into the neuroinflammatory processes of Parkinson's disease is ongoing, with many unanswered questions still remaining to be explored for the development of effective treatments.

MOVEMENT DISORDERS (2021)

Review Gastroenterology & Hepatology

The Microbiota-Gut-Brain Axis: From Motility to Mood

Kara G. Margolis et al.

Summary: The gut-brain axis is crucial in maintaining homeostasis, with the microbiome playing a significant role in modulating signaling along this axis. This axis impacts disorders like irritable bowel syndrome and mood disorders, with serotonin being a key neurotransmitter involved in these conditions. More research is needed before these findings can be applied for diagnostic and therapeutic purposes in patient populations.

GASTROENTEROLOGY (2021)

Letter Clinical Neurology

Increase of Prokineticin-2 in Serum of Patients with Parkinson's Disease

Tommaso Schirinzi et al.

MOVEMENT DISORDERS (2021)

Article Clinical Neurology

Soluble CD163 Changes Indicate Monocyte Association With Cognitive Deficits in Parkinson's Disease

Sara Konstantin Nissen et al.

Summary: This study found that sCD163 in the CSF of PD patients correlated with PD biomarkers and cognition scores, supporting monocyte involvement in neurodegeneration and cognition in PD. An increase in CSF-sCD163 in female patients suggested a sex-distinctive monocyte response. In vitro studies showed the potential connection between CD163 and alpha-synuclein, indicating a role for monocytes in both peripheral and brain immune responses to PD.

MOVEMENT DISORDERS (2021)

Review Clinical Neurology

Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?

Fangda Leng et al.

Summary: Microglial activation and neuroinflammation play important roles in Alzheimer's disease, affecting disease progression and pathologies. Current research focuses on the interplay between neuroinflammation and amyloid and tau pathologies, with a specific interest in modulating microglia as a therapeutic strategy for AD.

NATURE REVIEWS NEUROLOGY (2021)

Article Clinical Neurology

Lower Lymphocyte Count is Associated With Increased Risk of Parkinson's Disease

Melanie P. Jensen et al.

Summary: Lower lymphocyte count is associated with an increased risk of subsequent Parkinson's disease. Other blood markers, such as reductions in eosinophil counts, monocyte counts, and C-reactive protein, may also be related to increased disease risk, but only the association with lower lymphocyte count remains robust. Mendelian randomization analysis suggests a potential causal relationship between lower lymphocyte count and Parkinson's disease risk.

ANNALS OF NEUROLOGY (2021)

Article Immunology

Protein network exploration prioritizes targets for modulating neuroinflammation in Parkinson's disease

Marie-Amandine Bonte et al.

Summary: Parkinson's disease is a progressive neurodegenerative disease associated with neuroinflammation and a loss of dopaminergic neurons. The protein network involved in Parkinson's disease neuroinflammation includes various biological processes, with Toll-like Receptor Cascades and Interleukin 4, 10, and 13 signaling pathways being the most significantly enriched. Through network analysis, 8 key proteins with the highest ability to control the underlying biological processes of neuroinflammation were identified as potential drug targets.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Letter Clinical Neurology

Biofluids profile of alpha-Klotho in patients with Parkinson's disease

Giulia Maria Sancesario et al.

Summary: The study found two distinct pools of alpha-Klotho in the cerebrospinal fluid and serum of early-stage Parkinson's disease patients, with the former increased and the latter reduced. CSF alpha-Klotho was inversely associated with CSF alpha-synuclein levels, suggesting alpha-Klotho as a potential biomarker or therapeutic target in PD.

PARKINSONISM & RELATED DISORDERS (2021)

Article Neurosciences

Serum and Fecal Markers of Intestinal Inflammation and Intestinal Barrier Permeability Are Elevated in Parkinson's Disease

Laura Dumitrescu et al.

Summary: Parkinson's disease is characterized by alpha-synuclein misfolding with intraneuronal amyloid formation, low-grade neuroinflammatory changes, and selective neurodegeneration. Evidence suggests that the disease may originate in the gut, with markers of intestinal inflammation and barrier dysfunction linked to PD. Calprotectin and zonulin levels were found to be significantly higher in the serum and feces of PD patients, indicating a potential association between gut health and sporadic PD. More research in larger cohorts is needed to further investigate this relationship.

FRONTIERS IN NEUROSCIENCE (2021)

Review Clinical Neurology

Parkinson's disease and the gastrointestinal microbiome

Michal Lubomski et al.

JOURNAL OF NEUROLOGY (2020)

Article Clinical Neurology

Systemic activation of Nrf2 pathway in Parkinson's disease

Sara Petrillo et al.

MOVEMENT DISORDERS (2020)

Article Clinical Neurology

Plasma biomarkers of astrocytic and neuronal dysfunction in early- and late-onset Alzheimer's

Fanny M. Elahi et al.

ALZHEIMERS & DEMENTIA (2020)

Article Clinical Neurology

Differential leukocyte count is associated with clinical phenotype in Parkinson's disease

Tadashi Umehara et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)

Article Multidisciplinary Sciences

α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson's disease

Cecilia S. Lindestam Arlehamn et al.

NATURE COMMUNICATIONS (2020)

Article Neurosciences

Association of inflammatory factors and aging in Parkinson's disease

Hong Jin et al.

NEUROSCIENCE LETTERS (2020)

Review Clinical Neurology

Inflammation, Infectious Triggers, and Parkinson's Disease

Elisa Caggiu et al.

FRONTIERS IN NEUROLOGY (2019)

Article Immunology

Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease

Chin-Hsien Lin et al.

JOURNAL OF NEUROINFLAMMATION (2019)

Article Neurosciences

Plasma IL-6 and IL-17A Correlate with Severity of Motor and Non-Motor Symptoms in Parkinson's Disease

Holly F. Green et al.

JOURNAL OF PARKINSONS DISEASE (2019)

Review Neurosciences

Brain-First versus Gut-First Parkinson's Disease: A Hypothesis

Per Borghammer et al.

JOURNAL OF PARKINSONS DISEASE (2019)

Article Clinical Neurology

High ultrasensitive serum C-reactive protein may be related to freezing of gait in Parkinson's disease patients

Diego Santos-Garcia et al.

JOURNAL OF NEURAL TRANSMISSION (2019)

Article Multidisciplinary Sciences

Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's disease

Paraskevi Krashia et al.

NATURE COMMUNICATIONS (2019)

Review Neurosciences

Triggers, Facilitators, and Aggravators: Redefining Parkinson's Disease Pathogenesis

Michaela E. Johnson et al.

TRENDS IN NEUROSCIENCES (2019)

Article Biochemistry & Molecular Biology

Lipopolysaccharide from Gut Microbiota Modulates α-Synuclein Aggregation and Alters Its Biological Function

Dipita Bhattacharyya et al.

ACS CHEMICAL NEUROSCIENCE (2019)

Review Immunology

Autoimmunity in Parkinson's Disease: The Role of α-Synuclein-Specific T Cells

Francesca Garretti et al.

FRONTIERS IN IMMUNOLOGY (2019)

Article Clinical Neurology

Inflammation and fatigue in early, untreated Parkinson's Disease

K. Herlofson et al.

ACTA NEUROLOGICA SCANDINAVICA (2018)

Review Biochemistry & Molecular Biology

Aging and Parkinson's Disease: Inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis

Vittorio Calabrese et al.

FREE RADICAL BIOLOGY AND MEDICINE (2018)

Article Immunology

Abnormalities of age-related T cell senescence in Parkinson's disease

C. H. Williams-Gray et al.

JOURNAL OF NEUROINFLAMMATION (2018)

Review Cell Biology

The Role of Immunosenescence in Neurodegenerative Diseases

Erica Costantini et al.

MEDIATORS OF INFLAMMATION (2018)

Article Clinical Neurology

Stool Immune Profiles Evince Gastrointestinal Inflammation in Parkinson's Disease

Madelyn C. Houser et al.

MOVEMENT DISORDERS (2018)

Article Clinical Neurology

Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson's disease

Andreas Schwiertz et al.

PARKINSONISM & RELATED DISORDERS (2018)

Review Endocrinology & Metabolism

Inflammaging: a new immune-metabolic viewpoint for age-related diseases

Claudio Franceschi et al.

NATURE REVIEWS ENDOCRINOLOGY (2018)

Article Clinical Neurology

Peripheral blood inflammatory markers in early Parkinson's disease

Ryul Kim et al.

JOURNAL OF CLINICAL NEUROSCIENCE (2018)

Review Clinical Neurology

The glymphatic pathway in neurological disorders

Martin Kaag Rasmussen et al.

LANCET NEUROLOGY (2018)

Article Clinical Neurology

Inflammatory profile discriminates clinical subtypes in LRRK2-associated Parkinson's disease

K. Brockmann et al.

EUROPEAN JOURNAL OF NEUROLOGY (2017)

Review Biochemistry & Molecular Biology

Potential Modes of Intercellular -Synuclein Transmission

Dario Valdinocci et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Article Multidisciplinary Sciences

T cells from patients with Parkinson's disease recognize α-synuclein peptides

David Sulzer et al.

NATURE (2017)

Review Biochemistry & Molecular Biology

Should We Stop Saying 'Glia' and 'Neuroinflammation'?

Roser Masgrau et al.

TRENDS IN MOLECULAR MEDICINE (2017)

Review Gastroenterology & Hepatology

Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease

Alexa R. Weingarden et al.

GUT MICROBES (2017)

Article Clinical Neurology

Age-dependent defects of alpha-synuclein oligomer uptake in microglia and monocytes

Corinna Bliederhaeuser et al.

ACTA NEUROPATHOLOGICA (2016)

Article Biochemistry & Molecular Biology

Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease

Timothy R. Sampson et al.

Article Clinical Neurology

IL-6 serum levels are elevated in Parkinson's disease patients with fatigue compared to patients without fatigue

Jessica Ramos Pereira et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)

Article Clinical Neurology

Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD)

Caroline H. Williams-Gray et al.

MOVEMENT DISORDERS (2016)

Article Clinical Neurology

Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls

Marcus M. Unger et al.

PARKINSONISM & RELATED DISORDERS (2016)

Article Clinical Neurology

Colonic Bacterial Composition in Parkinson's Disease

Ali Keshavarzian et al.

MOVEMENT DISORDERS (2015)

Article Clinical Neurology

Increased CSF biomarkers of angiogenesis in Parkinson disease

Shorena Janelidze et al.

NEUROLOGY (2015)

Article Clinical Neurology

Gut Microbiota Are Related to Parkinson's Disease and Clinical Phenotype

Filip Scheperjans et al.

MOVEMENT DISORDERS (2015)

Article Multidisciplinary Sciences

Baseline C-Reactive Protein Levels and Life Prognosis in Parkinson Disease

Hideyuki Sawada et al.

PLOS ONE (2015)

Article Immunology

Heat shock protein 60: an endogenous inducer of dopaminergic cell death in Parkinson disease

Carmen Noelker et al.

JOURNAL OF NEUROINFLAMMATION (2014)

Article Genetics & Heredity

Association of Parkinson Disease with Structural and Regulatory Variants in the HLA Region

William T. Wissemann et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2013)

Article Biochemistry & Molecular Biology

A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinsons disease

Peter Holmans et al.

HUMAN MOLECULAR GENETICS (2013)

Review Neurosciences

Inflammation and α-Synuclein's Prion-like Behavior in Parkinson's Disease-Is There a Link?

Carla M. Lema Tome et al.

MOLECULAR NEUROBIOLOGY (2013)

Article Multidisciplinary Sciences

Genomic responses in mouse models poorly mimic human inflammatory diseases

Junhee Seok et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Multidisciplinary Sciences

Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease

Carmen Noelker et al.

SCIENTIFIC REPORTS (2013)

Article Clinical Neurology

Increased Intestinal Permeability and Parkinson Disease Patients: Chicken or Egg?

D. Salat-Foix et al.

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2012)

Review Gastroenterology & Hepatology

On communication between gut microbes and the brain

Paul Forsythe et al.

CURRENT OPINION IN GASTROENTEROLOGY (2012)

Article Neurosciences

CD4+Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson's Disease

Jessica A. Hutter Saunders et al.

JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2012)

Review Multidisciplinary Sciences

Host-Gut Microbiota Metabolic Interactions

Jeremy K. Nicholson et al.

SCIENCE (2012)

Article Clinical Neurology

Cerebrospinal Fluid Biomarkers for Parkinson Disease Diagnosis and Progression

Min Shi et al.

ANNALS OF NEUROLOGY (2011)

Review Neurosciences

Heterogeneity of CNS myeloid cells and their roles in neurodegeneration

Marco Prinz et al.

NATURE NEUROSCIENCE (2011)

Article Multidisciplinary Sciences

Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism

Francisco Ros-Bernal et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Review Clinical Neurology

Neuroinflammation in Parkinson's disease: a target for neuroprotection?

Etienne C. Hirsch et al.

LANCET NEUROLOGY (2009)

Article Geriatrics & Gerontology

Synuclein activates microglia in a model of Parkinson's disease

Xiaomin Su et al.

NEUROBIOLOGY OF AGING (2008)

Article Multidisciplinary Sciences

Nitrated α-Synuclein Immunity Accelerates Degeneration of Nigral Dopaminergic Neurons

Eric J. Benner et al.

PLOS ONE (2008)

Article Biochemistry & Molecular Biology

Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease

Ashley D. Reynolds et al.

JOURNAL OF NEUROCHEMISTRY (2008)

Article Public, Environmental & Occupational Health

Peripheral inflammatory biomarkers and risk of Parkinson's disease

Honglei Chen et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)

Article Clinical Neurology

Circulating interleukin-15 and RANTES chemokine in Parkinson's disease

M. Rentzos et al.

ACTA NEUROLOGICA SCANDINAVICA (2007)

Article Clinical Neurology

Blood-brain barrier dysfunction in Parkinsonian midbrain in vivo

R Kortekaas et al.

ANNALS OF NEUROLOGY (2005)

Article Clinical Neurology

Changes in vascularization in substantia nigra pars compacta of monkeys rendered parkinsonian

C Barcia et al.

JOURNAL OF NEURAL TRANSMISSION (2005)

Review Geriatrics & Gerontology

Staging of brain pathology related to sporadic Parkinson's disease

H Braak et al.

NEUROBIOLOGY OF AGING (2003)